{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:18:37Z","timestamp":1788452317763,"version":"build-2803163510"},"reference-count":80,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pet.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cpet.2026.07.001","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:38:28Z","timestamp":1788449908000},"page":"483-497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["FDG-PET in Cognitive Impairment and Dementia"],"prefix":"10.1016","volume":"21","author":[{"given":"Julie","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.S.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpet.2026.07.001_bib1","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.cpet.2026.07.001_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.cpet.2026.07.001_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.cpet.2026.07.001_bib4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.cpet.2026.07.001_bib5","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.cpet.2026.07.001_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/archneur.64.4.535","article-title":"Clinical and psychometric distinction of frontotemporal and Alzheimer dementias","volume":"64","author":"Liscic","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.cpet.2026.07.001_bib7","first-page":"619","article-title":"Dementia with Lewy bodies: definition, diagnosis, and pathogenic relationship to Alzheimer\u2019s disease","volume":"3","author":"Mrak","year":"2007","journal-title":"Neuropsychiatric Dis Treat"},{"key":"10.1016\/j.cpet.2026.07.001_bib8","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.cpet.2026.07.001_bib9","first-page":"4250","article-title":"In vivo FDG-PET metabolic signature of limbic-predominant age-related TDP-43 encephalopathy neuropathologic change","volume":"19","author":"Grothe","year":"2023","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.cpet.2026.07.001_bib10","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3233\/JAD-2012-111400","article-title":"Co-occurrence of different pathologies in dementia: implications for dementia diagnosis","volume":"30","author":"Echavarri","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.cpet.2026.07.001_bib11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the NIA-AA workgroups","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.cpet.2026.07.001_bib12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.cpet.2026.07.001_bib13","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJMoa2310168","article-title":"Biomarker changes during 20 years preceding Alzheimer\u2019s disease","volume":"390","author":"Jia","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpet.2026.07.001_bib14","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.cpet.2026.07.001_bib15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the International Working Group","volume":"20","author":"Dubois","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.cpet.2026.07.001_bib16","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/jamaneurol.2024.3770","article-title":"Alzheimer disease as a clinical-biological construct\u2014an International Working Group recommendation","volume":"81","author":"Dubois","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.cpet.2026.07.001_bib17","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.286.17.2120","article-title":"Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome","volume":"286","author":"Silverman","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.cpet.2026.07.001_bib18","first-page":"594","article-title":"Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluation","volume":"45","author":"Silverman","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpet.2026.07.001_bib19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.25968","article-title":"Diagnostic accuracy of amyloid versus 18F-fluorodeoxyglucose positron emission tomography in autopsy-confirmed dementia","volume":"89","author":"Lesman-Segev","year":"2021","journal-title":"Ann Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.cpet.2026.07.001_bib20","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.2967\/jnumed.121.263194","article-title":"18F-FDG PET imaging in neurodegenerative dementing disorders: insights into subtype classification, emerging disease categories, and mixed dementia with copathologies","volume":"63","author":"Minoshima","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpet.2026.07.001_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/jon.70080","article-title":"Functional imaging in Alzheimer\u2019s disease: a systematic review and meta-analysis of ASL-MRI and FDG-PET","volume":"35","author":"Radmard","year":"2025","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.cpet.2026.07.001_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","article-title":"Metabolic reduction in the posterior cingulate cortex in very early Alzheimer\u2019s disease","volume":"42","author":"Minoshima","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cpet.2026.07.001_bib23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the NIA-AA workgroups","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.cpet.2026.07.001_bib24","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00259-017-3634-3","article-title":"Value of FDG-PET scans of non-demented patients in predicting rates of future cognitive and functional decline","volume":"44","author":"Torosyan","year":"2017","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.cpet.2026.07.001_bib25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000441776","article-title":"Comparison between early-onset and late-onset Alzheimer\u2019s disease patients with amnestic presentation: CSF and 18F-FDG PET study","volume":"6","author":"Chiaravalloti","year":"2016","journal-title":"Dement Geriatr Cogn Disord Extra"},{"key":"10.1016\/j.cpet.2026.07.001_bib26","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1212\/WNL.0000000000000734","article-title":"Dementia with Lewy bodies: basis of cingulate island sign","volume":"83","author":"Graff-Radford","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.cpet.2026.07.001_bib27","first-page":"1238","article-title":"A diagnostic approach in Alzheimer\u2019s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET","volume":"36","author":"Minoshima","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpet.2026.07.001_bib28","first-page":"e1774","article-title":"FDG PET metabolic signatures distinguishing prodromal DLB from prodromal AD","volume":"97","author":"Nedelska","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.cpet.2026.07.001_bib29","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1093\/brain\/awm177","article-title":"FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer\u2019s disease","volume":"130","author":"Foster","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.cpet.2026.07.001_bib30","first-page":"233","article-title":"18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients","volume":"46","author":"Jeong","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpet.2026.07.001_bib31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ana.20799","article-title":"Brain imaging evidence of preclinical Alzheimer\u2019s disease in normal aging","volume":"59","author":"Jagust","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cpet.2026.07.001_bib32","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1007\/s00259-024-06631-y","article-title":"Molecular imaging for predicting conversion from mild cognitive impairment to dementia: an updated systematic review","volume":"51","author":"Cotta Ramusino","year":"2024","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.cpet.2026.07.001_bib33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1176\/ajp.154.2.165","article-title":"Association of premorbid intellectual function with cerebral metabolism in Alzheimer\u2019s disease: implications for the cognitive reserve hypothesis","volume":"154","author":"Alexander","year":"1997","journal-title":"Am J Psychiatry"},{"issue":"Suppl","key":"10.1016\/j.cpet.2026.07.001_bib34","article-title":"Biological and clinical heterogeneity of amnestic mild cognitive impairment revealed by FDG-PET metabolic subtypes","volume":"19","author":"Perani","year":"2023","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.cpet.2026.07.001_bib35","first-page":"1254","article-title":"FDG-PET metabolic phenotypes of amnestic MCI: implications for prognosis and clinical trial design","volume":"20","author":"Perani","year":"2024","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.cpet.2026.07.001_bib36","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1007\/s00259-025-07228-9","article-title":"Diagnostic performance of deep learning-assisted [18F]FDG PET imaging for Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"52","author":"Sun","year":"2025","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.cpet.2026.07.001_bib37","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00259-021-05483-0","article-title":"A 3D deep learning model to predict the diagnosis of dementia with lewy bodies, Alzheimer\u2019s disease, and mild cognitive impairment using brain 18F-FDG PET","volume":"49","author":"Etminani","year":"2022","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.cpet.2026.07.001_bib38","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00259-021-05603-w","article-title":"EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3","volume":"49","author":"Guedj","year":"2022","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.cpet.2026.07.001_bib39","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S1474-4422(23)00447-7","article-title":"European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders","volume":"23","author":"Frisoni","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.cpet.2026.07.001_bib40","first-page":"1810","article-title":"SNMMI\/EANM practice guideline for brain FDG PET, version 2.0","volume":"65","author":"Arbizu","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpet.2026.07.001_bib41","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006213","article-title":"Brain imaging in Alzheimer disease","volume":"2","author":"Johnson","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.cpet.2026.07.001_bib42","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/jamaneurol.2022.3157","article-title":"Racial and ethnic differences in amyloid PET positivity in individuals with mild cognitive impairment or dementia: a secondary analysis of the IDEAS study","volume":"79","author":"Wilkins","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.cpet.2026.07.001_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1053\/j.semnuclmed.2016.09.005","article-title":"Clinical amyloid imaging","volume":"47","author":"Mallik","year":"2017","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.cpet.2026.07.001_bib44","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1093\/brain\/aww193","article-title":"Amyloid-\u03b2 deposition and regional grey matter atrophy rates in dementia with lewy bodies","volume":"139","author":"Sarro","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.cpet.2026.07.001_bib45","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/cns.12476","article-title":"Cerebrospinal fluid A\u03b242 levels: when physiological become pathological state","volume":"21","author":"Martorana","year":"2015","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.cpet.2026.07.001_bib46","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jama.2019.2000","article-title":"Association of amyloid positron emission tomography with subsequent change in clinical management among Medicare beneficiaries with mild cognitive impairment or dementia","volume":"321","author":"Rabinovici","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.cpet.2026.07.001_bib47","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/jamaneurol.2023.3490","article-title":"Amyloid PET and subsequent health care use among Medicare beneficiaries with mild cognitive impairment or dementia (IDEAS study, aim 2)","volume":"80","author":"Rabinovici","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.cpet.2026.07.001_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70504","article-title":"New IDEAS study: amyloid PET in a racially and ethnically diverse population","volume":"21","author":"Windon","year":"2025","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.cpet.2026.07.001_bib49","unstructured":"Centers for Medicare and Medicaid Services. Retirement of National Coverage Determination 220.6.20 for beta amyloid positron emission tomography in dementia and neurodegenerative disease. 2023."},{"key":"10.1016\/j.cpet.2026.07.001_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14338","article-title":"Updated appropriate use criteria for amyloid and tau PET","volume":"21","author":"Rabinovici","year":"2025","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.cpet.2026.07.001_bib51","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/s43587-023-00471-5","article-title":"A two-step workflow based on plasma p-tau217 to screen for amyloid \u03b2 positivity with further confirmatory testing only in uncertain cases","volume":"3","author":"Brum","year":"2023","journal-title":"Nat Aging"},{"key":"10.1016\/j.cpet.2026.07.001_bib52","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jama.2024.13855","article-title":"Blood biomarkers to detect Alzheimer disease in primary care and secondary care","volume":"332","author":"Palmqvist","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.cpet.2026.07.001_bib53","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41591-024-02869-z","article-title":"Highly accurate blood test for Alzheimer\u2019s disease is similar or superior to clinical cerebrospinal fluid tests","volume":"30","author":"Barth\u00e9lemy","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.cpet.2026.07.001_bib54","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.21955","article-title":"Relationship between atrophy and \u03b2-amyloid deposition in Alzheimer disease","volume":"67","author":"Chetelat","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cpet.2026.07.001_bib55","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/brain\/awl178","article-title":"Two-year follow-up of amyloid deposition in patients with Alzheimer\u2019s disease","volume":"129","author":"Engler","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.cpet.2026.07.001_bib56","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.3390\/diagnostics13132254","article-title":"FDG PET for monitoring immunotherapy in Alzheimer\u2019s disease","volume":"13","author":"H\u00f8ilund-Carlsen","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.cpet.2026.07.001_bib57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpet.2026.07.001_bib58","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.cpet.2026.07.001_bib59","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nn.4018","article-title":"Three dimensions of the amyloid hypothesis: time, space and \u201cwingmen.\u201d","volume":"18","author":"Musiek","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.cpet.2026.07.001_bib60","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.3174\/ajnr.A3644","article-title":"An expanded role for neuroimaging in the evaluation of memory impairment","volume":"34","author":"Desikan","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.cpet.2026.07.001_bib61","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1093\/brain\/awx243","article-title":"Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease","volume":"140","author":"Bejanin","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.cpet.2026.07.001_bib62","first-page":"1786","article-title":"Tau pathology is associated with synaptic density and longitudinal synaptic loss in Alzheimer\u2019s disease","volume":"29","author":"Guo","year":"2024","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.cpet.2026.07.001_bib63","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaneurol.2021.1858","article-title":"Accuracy of tau positron emission tomography as a prognostic marker in preclinical and prodromal Alzheimer disease","volume":"78","author":"Ossenkoppele","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.cpet.2026.07.001_bib64","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1038\/s41591-022-02049-x","article-title":"Amyloid- and tau-PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline","volume":"28","author":"Ossenkoppele","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.cpet.2026.07.001_bib65","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41593-025-02000-6","article-title":"Tau PET positivity varies with age, amyloid status, APOE genotype, and sex across the Alzheimer\u2019s disease spectrum","volume":"28","author":"Ossenkoppele","year":"2025","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.cpet.2026.07.001_bib66","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s43587-022-00204-0","article-title":"Biomarker modeling of Alzheimer\u2019s disease using PET-based Braak staging","volume":"2","author":"Therriault","year":"2022","journal-title":"Nat Aging"},{"key":"10.1016\/j.cpet.2026.07.001_bib67","article-title":"Comparison of tau-PET tracers for in vivo Braak staging: the HEAD study","volume":"20","author":"Fernandez-Arias","year":"2024","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.cpet.2026.07.001_bib68","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2967\/jnumed.120.254961","article-title":"Direct comparison of the tau PET tracers [18F]flortaucipir and [18F]MK-6240 in human subjects","volume":"63","author":"Gogola","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpet.2026.07.001_bib69","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.neuroimage.2010.12.073","article-title":"Antemortem differential diagnosis of dementia pathology using structural MRI: differential\u2013STAND","volume":"55","author":"Vemuri","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.cpet.2026.07.001_bib70","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1038\/s41467-022-31037-5","article-title":"Multimodal deep learning for Alzheimer\u2019s disease dementia assessment","volume":"13","author":"Qiu","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.cpet.2026.07.001_bib71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13195-022-00985-x","article-title":"A deep learning MRI approach outperforms other biomarkers of prodromal Alzheimer\u2019s disease","volume":"14","author":"Feng","year":"2022","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.cpet.2026.07.001_bib72","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.3174\/ajnr.A7586","article-title":"Amyloid-related imaging abnormalities with emerging Alzheimer disease therapeutics: detection and reporting recommendations for clinical practice","volume":"43","author":"Cogswell","year":"2022","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.cpet.2026.07.001_bib73","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14283\/jpad.2023.30","article-title":"Lecanemab: appropriate use recommendations","volume":"10","author":"Cummings","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.cpet.2026.07.001_bib74","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3174\/ajnr.A8469","article-title":"ARIA monitoring in clinical practice: updated considerations for anti-amyloid immunotherapy","volume":"46","author":"Cogswell","year":"2025","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.cpet.2026.07.001_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-200487","article-title":"Optimizing use of neuroimaging tools in evaluation of Alzheimer\u2019s disease and related dementias","volume":"77","author":"Raji","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.cpet.2026.07.001_bib76","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1468-1331.2006.01605.x","article-title":"Recommendations for the diagnosis and management of Alzheimer\u2019s disease and other disorders associated with dementia: EFNS guideline","volume":"14","author":"Waldemar","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.cpet.2026.07.001_bib77","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1468-1331.2010.03040.x","article-title":"EFNS guidelines for the diagnosis and management of Alzheimer\u2019s disease","volume":"17","author":"Hort","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.cpet.2026.07.001_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1395413","article-title":"Practical use of DAT SPECT in diagnosing dementia with Lewy bodies: a US perspective","volume":"15","author":"O\u2019Shea","year":"2024","journal-title":"Front Neurol"},{"key":"10.1016\/j.cpet.2026.07.001_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","article-title":"The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET","volume":"11","author":"Klunk","year":"2015","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.cpet.2026.07.001_bib80","article-title":"CenTauR: toward a universal scale and masks for standardizing tau imaging studies","volume":"15","author":"Villemagne","year":"2023","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155685982600074X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155685982600074X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:38:38Z","timestamp":1788449918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155685982600074X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S155685982600074X"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2026.07.001","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FDG-PET in Cognitive Impairment and Dementia","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2026.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}